This list is an analysis based on recent market events. It's not an investment recommendation.
About
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company's commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is based in Hangzhou, the People's Republic of China.
The current price of ASCLF is $1.81 USD — it has decreased by -4.74% in the past 24 hours. Watch Ascletis Pharma stock price performance more closely on the chart.
What is Ascletis Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ascletis Pharma stocks are traded under the ticker ASCLF.
What is Ascletis Pharma market cap?▼
Today Ascletis Pharma has the market capitalization of 2.84B
When is the next Ascletis Pharma earnings date?▼
Ascletis Pharma is going to release the next earnings report on August 24, 2026.
What is Ascletis Pharma revenue for the last year?▼
Ascletis Pharma revenue for the last year amounts to 351,656.18 USD.
What is Ascletis Pharma net income for the last year?▼
ASCLF net income for the last year is -82.56M USD.
How many employees does Ascletis Pharma have?▼
As of April 01, 2026, the company has 231 employees.
In which sector is Ascletis Pharma located?▼
Ascletis Pharma operates in the Health Care sector.
When did Ascletis Pharma complete a stock split?▼
Ascletis Pharma has not had any recent stock splits.